Jonathan Sherman is a member of the Cassels Brock & Blackwell LLP Cannabis Group and assists a broad range of industry participants, including licensed producers in both Canada and the United States, pre-licensed applicants in Canada and abroad as well as a variety of ancillary businesses in the sector.
Jonathan represents public and private companies and investment dealers in domestic and cross-border transactions and advises issuers with respect to general corporate and securities law matters, mergers and acquisitions, corporate finance and go-public transactions, joint ventures, alternative financing solutions and other corporate commercial transactions.
Jonathan’s representative work includes various corporate and commercial transactions for Canopy Growth Corporation as well as Canopy Rivers Corporation, the strategic investment platform formed by Canopy Growth in order to provide growth capital to licensed producers and pre-licensed applicants. In addition, he recently assisted Canopy Growth with its expansion into New Brunswick and Canopy Rivers with their initial financing rounds and strategic investment transactions.
Jonathan is also a regular contributor to the Canadian Life Sciences blog at Cassels Brock, having authored articles with respect to alternative financing options, exports under the current medical cannabis regime and other regulatory and licensing developments in both the medical and adult-use markets.
